Reneo Pharmaceuticals News

Reneo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-OCTAGON CAPITAL ADVISORS LP(6.75%),OCTAGON INVESTMENTS MASTER FUND LP(6.75%), etc.

Feb 5 16:05 ET

Reneo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Braden M Leonard(5.1%),BML Investment Partners, L.P.(4.1%)

Jan 17 00:00 ET

Reneo Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(9.996%),TANG CAPITAL MANAGEMENT, LLC(9.996%), etc.

Dec 26, 2023 00:00 ET

Reneo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(0%)

Dec 15, 2023 16:55 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hall Ashley

Aug 29, 2023 17:04 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Executive Chairman GREY MICHAEL G

Jul 27, 2023 17:16 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Novo Holdings A/S

Jun 23, 2023 19:15 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T

Jun 8, 2023 20:09 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Blunt Roshawn A.

Jun 8, 2023 18:17 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Executive Chairman GREY MICHAEL G

Jun 8, 2023 18:16 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hoelscher Paul W.

Jun 8, 2023 18:15 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Muralidhar Bali

Jun 8, 2023 18:14 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director O'Donnell Niall

Jun 8, 2023 18:13 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Seltzer Stacey Denenberg

Jun 8, 2023 18:06 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dube Eric M

Jun 8, 2023 18:02 ET

Reneo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.R.S. IDENTIFICATION NO. John P. McKearn, Ph.D.(7.53%),I.R.S. IDENTIFICATION NO. Jay Schmelter(7.53%), etc.

May 30, 2023 16:52 ET

Reneo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(10.2%)

May 15, 2023 17:16 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director O'Donnell Niall

May 10, 2023 17:47 ET

Reneo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Carlyle Group Inc.(8.2%),Carlyle Holdings I GP Inc.(8.2%), etc.

May 9, 2023 16:31 ET

Reneo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Dec 13, 2022 18:13 ET